48 related articles for article (PubMed ID: 31923538)
21. Droplet Microfluidics for Tumor Drug-Related Studies and Programmable Artificial Cells.
Dimitriou P; Li J; Tornillo G; McCloy T; Barrow D
Glob Chall; 2021 Jul; 5(7):2000123. PubMed ID: 34267927
[TBL] [Abstract][Full Text] [Related]
22. Novel PVA-Based Microspheres Co-Loaded with Photothermal Transforming Agent and Chemotherapeutic for Colorectal Cancer Treatment.
Zhang Y; He Z; Yang F; Ye C; Xu X; Wang S; Zhang L; Zou D
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34209684
[TBL] [Abstract][Full Text] [Related]
23. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients.
Ginghină O; Hudiță A; Zaharia C; Tsatsakis A; Mezhuev Y; Costache M; Gălățeanu B
Materials (Basel); 2021 May; 14(9):. PubMed ID: 34066710
[TBL] [Abstract][Full Text] [Related]
24. Identification of Hub Genes and Construction of a Transcriptional Regulatory Network Associated With Tumor Recurrence in Colorectal Cancer by Weighted Gene Co-expression Network Analysis.
Liu S; Zeng F; Fan G; Dong Q
Front Genet; 2021; 12():649752. PubMed ID: 33897765
[TBL] [Abstract][Full Text] [Related]
25. Overcoming Biological Barriers With Block Copolymers-Based Self-Assembled Nanocarriers. Recent Advances in Delivery of Anticancer Therapeutics.
Torres J; Dhas N; Longhi M; García MC
Front Pharmacol; 2020; 11():593197. PubMed ID: 33329001
[TBL] [Abstract][Full Text] [Related]
26. Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells.
Haddad Y; Charousova M; Zivotska H; Splichal Z; Merlos Rodrigo MA; Michalkova H; Krizkova S; Tesarova B; Richtera L; Vitek P; Stokowa-Soltys K; Hynek D; Milosavljevic V; Rex S; Heger Z
J Nanobiotechnology; 2020 Jul; 18(1):95. PubMed ID: 32660596
[TBL] [Abstract][Full Text] [Related]
27. Gene Therapy in Cancer Treatment: Why Go Nano?
Roma-Rodrigues C; Rivas-García L; Baptista PV; Fernandes AR
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32151052
[TBL] [Abstract][Full Text] [Related]
28. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases.
Li C; Zhou L; Yin X
Front Pharmacol; 2024; 15():1342181. PubMed ID: 38500764
[TBL] [Abstract][Full Text] [Related]
30. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
31. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting Multidrug Resistance with Transferrin-Targeted Polymersomes through Optimization of Ligand Density.
Yi SL; Li ZL; Gong YC; Xiong XY
Langmuir; 2023 Nov; 39(45):15920-15931. PubMed ID: 37922445
[TBL] [Abstract][Full Text] [Related]
33. ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice.
Zhang N; Xia Y; Zou Y; Yang W; Zhang J; Zhong Z; Meng F
Mol Pharm; 2017 Aug; 14(8):2538-2547. PubMed ID: 28005375
[TBL] [Abstract][Full Text] [Related]
34. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
35. Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo.
Wei Y; Gu X; Sun Y; Meng F; Storm G; Zhong Z
J Control Release; 2020 Mar; 319():407-415. PubMed ID: 31923538
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
